WD Rutherford LLC Makes New Investment in The Cooper Companies, Inc. $COO

WD Rutherford LLC purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 8,201 shares of the medical device company’s stock, valued at approximately $562,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Cooper Companies by 48.9% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock valued at $1,890,000 after purchasing an additional 7,363 shares during the last quarter. UniSuper Management Pty Ltd boosted its position in Cooper Companies by 14.9% during the first quarter. UniSuper Management Pty Ltd now owns 27,919 shares of the medical device company’s stock valued at $2,355,000 after acquiring an additional 3,625 shares during the last quarter. United Services Automobile Association acquired a new stake in Cooper Companies during the 1st quarter worth about $414,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its holdings in Cooper Companies by 15.5% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,121,835 shares of the medical device company’s stock worth $178,977,000 after acquiring an additional 284,943 shares during the period. Finally, Voya Investment Management LLC raised its position in shares of Cooper Companies by 33.5% in the 1st quarter. Voya Investment Management LLC now owns 237,239 shares of the medical device company’s stock worth $20,011,000 after acquiring an additional 59,544 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cooper Companies

In other news, Director Cynthia L. Lucchese acquired 1,784 shares of the business’s stock in a transaction on Monday, December 22nd. The shares were purchased at an average cost of $84.06 per share, with a total value of $149,963.04. Following the acquisition, the director directly owned 9,445 shares of the company’s stock, valued at $793,946.70. The trade was a 23.29% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Tuesday, December 16th. The stock was purchased at an average price of $80.80 per share, with a total value of $808,000.00. Following the purchase, the chief executive officer owned 236,151 shares in the company, valued at approximately $19,081,000.80. This represents a 4.42% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last quarter, insiders bought 16,014 shares of company stock valued at $1,304,416. Corporate insiders own 1.98% of the company’s stock.

Analyst Ratings Changes

COO has been the subject of several recent analyst reports. Morgan Stanley raised their target price on Cooper Companies from $76.00 to $83.00 and gave the stock an “equal weight” rating in a research note on Monday, December 8th. The Goldman Sachs Group restated a “sell” rating and set a $71.00 price target (up from $64.00) on shares of Cooper Companies in a report on Monday, December 8th. Robert W. Baird raised their price objective on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a research report on Friday, December 5th. Mizuho set a $100.00 target price on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Friday, December 5th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research note on Friday, December 5th. One analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $90.15.

Cooper Companies Price Performance

Shares of COO opened at $83.90 on Thursday. The stock has a market cap of $16.44 billion, a P/E ratio of 44.63, a P/E/G ratio of 2.41 and a beta of 1.03. The business’s fifty day moving average is $77.40 and its 200 day moving average is $73.15. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $100.24.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.11 by $0.04. The firm had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.06 billion. Cooper Companies had a net margin of 9.16% and a return on equity of 10.02%. The business’s revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.04 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its Board of Directors has authorized a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.